Loading…
Reported covered position: LEGISLATIVE CORRESPONDENT, REP. VAN HOLLEN
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Human Cloning Ban Act of 2005
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 658, Human Cloning Prohibition Act H.R. 1357, Human Cloning Prohibition Act S. 1955, Health Insurance Marketplace Modernization and Affordability Act S. 2754, Alternative Pluripotent Stem Cell Therapies Enhancement Act H.R. 6164, National Institutes of Health Reauthorization Bill H.R. 810, Stem Cell Research Enhancement Act S. 1520, Human Cloning Ban Act S. 876/H.R. 1822, Human Cloning Ban and Stem Cell Research Protection Act
Alternative Pluripotent Stem Cell Therapies Enhancement Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2006 · year_end · YY
S. 658, Human Cloning Prohibition Act H.R. 1357, Human Cloning Prohibition Act S. 1955, Health Insurance Marketplace Modernization and Affordability Act S. 2754, Alternative Pluripotent Stem Cell Therapies Enhancement Act H.R. 6164, National Institutes of Health Reauthorization Bill H.R. 810, Stem Cell Research Enhancement Act S. 1520, Human Cloning Ban Act S. 876/H.R. 1822, Human Cloning Ban and Stem Cell Research Protection Act
Rule changes issued by the Office of Personnel Management that affected certain charities participating in the Combined Federal Campaign
Source: Senate LDA
S. 658, Human Cloning Prohibition Act H.R. 1357, Human Cloning Prohibition Act S. 1955, Health Insurance Marketplace Modernization and Affordability Act S. 2754, Alternative Pluripotent Stem Cell Therapies Enhancement Act H.R. 6164, National Institutes of Health Reauthorization Bill H.R. 810, Stem Cell Research Enhancement Act S. 1520, Human Cloning Ban Act S. 876/H.R. 1822, Human Cloning Ban and Stem Cell Research Protection Act
Human Cloning Prohibition Act of 2005
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 658, Human Cloning Prohibition Act H.R. 1357, Human Cloning Prohibition Act S. 1955, Health Insurance Marketplace Modernization and Affordability Act S. 2754, Alternative Pluripotent Stem Cell Therapies Enhancement Act H.R. 6164, National Institutes of Health Reauthorization Bill H.R. 810, Stem Cell Research Enhancement Act S. 1520, Human Cloning Ban Act S. 876/H.R. 1822, Human Cloning Ban and Stem Cell Research Protection Act
Human Cloning Ban and Stem Cell Research Protection Act of 2005
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 658, Human Cloning Prohibition Act H.R. 1357, Human Cloning Prohibition Act S. 1955, Health Insurance Marketplace Modernization and Affordability Act S. 2754, Alternative Pluripotent Stem Cell Therapies Enhancement Act H.R. 6164, National Institutes of Health Reauthorization Bill H.R. 810, Stem Cell Research Enhancement Act S. 1520, Human Cloning Ban Act S. 876/H.R. 1822, Human Cloning Ban and Stem Cell Research Protection Act
Discuss emerging technologies for diabetes management
FY 2007 Departments of Labor, Health & Human Services, Education & Related Agencies Appropriations FY 2007 Department of Defense Appropriations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM), SENATE